Karagianni, F.; Piperi, C.; Valero-Diaz, S.; Amato, C.; Vaque, J.P.; Casar, B.; Papadavid, E.
Combination of JAKi and HDACi Exerts Antiangiogenic Potential in Cutaneous T-Cell Lymphoma. Cancers 2024, 16, 3176.
https://doi.org/10.3390/cancers16183176
AMA Style
Karagianni F, Piperi C, Valero-Diaz S, Amato C, Vaque JP, Casar B, Papadavid E.
Combination of JAKi and HDACi Exerts Antiangiogenic Potential in Cutaneous T-Cell Lymphoma. Cancers. 2024; 16(18):3176.
https://doi.org/10.3390/cancers16183176
Chicago/Turabian Style
Karagianni, Fani, Christina Piperi, Sara Valero-Diaz, Camilla Amato, Jose Pedro Vaque, Berta Casar, and Evangelia Papadavid.
2024. "Combination of JAKi and HDACi Exerts Antiangiogenic Potential in Cutaneous T-Cell Lymphoma" Cancers 16, no. 18: 3176.
https://doi.org/10.3390/cancers16183176
APA Style
Karagianni, F., Piperi, C., Valero-Diaz, S., Amato, C., Vaque, J. P., Casar, B., & Papadavid, E.
(2024). Combination of JAKi and HDACi Exerts Antiangiogenic Potential in Cutaneous T-Cell Lymphoma. Cancers, 16(18), 3176.
https://doi.org/10.3390/cancers16183176